Shree Ganesh Biotech (India) share news, announcements and annual reports
BSE: 539470Pharmaceuticals & BiotechnologySmall Cap
Shree Ganesh Biotech (India) Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2015
Last close ₹0.45up ₹0.02 (4.65%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.43.
2 Nov: open ₹0.44, high ₹0.45, low ₹0.43
52-week range of traded prices to 2 Nov 2026
₹0.40Low, 30 Oct 2026₹0.75High, 3 Nov 2025
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18 Cr3,998th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,43,142
Shree Ganesh Biotech (India) share news and announcements
463 announcements, routine notices left out, newest first. Page 2 of 10.
Jan 2025
Oct 2024
15 Oct · Board meeting
Meeting on 23 Oct 2024: quarterly results
Sep 2024
28 Sep · Meeting
28 Sep · Meeting
Aug 2024
Jul 2024
30 Jul · Board meeting
Meeting on 13 Aug 2024: quarterly results
May 2024
30 May · Board meeting
30 May · Results
22 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
Feb 2024
Jan 2024
18 Jan · Board meeting
Meeting on 13 Feb 2024: quarterly results
Dec 2023
28 Dec · Advisory Letter Received From BSE Limited Dated 28.12.2023
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Sep 2023
28 Sep · Meeting
28 Sep · Meeting
11 Sep · Management